PetVivo Holdings, Inc.
PETVOTCHealthcare · Surgical & Medical Instruments & Apparatus · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1M | $968,706 | $917,162 | $115,586 | $12,578 | $3,588 |
| Operating income | −$8.1M | −$10.6M | −$8.7M | −$5.1M | −$2.0M | −$2.0M |
| Net income | −$8.4M | −$11.0M | −$8.7M | −$5.0M | −$3.5M | −$2.1M |
| Total assets | $9.3M | $3.1M | $2.4M | $7.4M | $835,247 | $522,517 |
| Total liabilities | $5.1M | $2.4M | $1.7M | $1.4M | $1.7M | $1.6M |
| Equity | $4.2M | $685,953 | $725,025 | $6.0M | −$896,979 | −$1.0M |
| EPS (diluted) | $-0.41 | $-0.78 | $-0.85 | $-0.57 | $-0.57 | — |
| Shares out. | 24.4M | 19.9M | 11.8M | 10.0M | 7.0M | 23.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −711.3%
- Net margin
- −741.6%
- Return on equity
- −199.1%
- Return on assets
- −89.9%
- Return on capital (ROCE)
- −160.4%
- Liabilities / assets
- 54.8%
- Debt / equity
- 1.21×
- Book value / share
- $0.17
- Revenue growth (YoY)
- 16.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -35.86distress
- Accruals / assets
- −32.9%clean
- Beneish M-Score
- -2.18normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Jun 30, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2019
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2019
- NT 10-Kmissed a reporting deadline ↗Jul 1, 2019
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2018
- NT 10-Kmissed a reporting deadline ↗Jun 28, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- A.L. Sarroff Fund, LlcActivist (13D)Mar 13, 2026
- Cruden Stanley CPassive (13G)Jan 20, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 24,710 | 1.5 | -5.4% |
| Apr 30, 2026 | 26,127 | 2.8 | +0.6% |
| Apr 15, 2026 | 25,980 | 1.6 | +2.3% |
| Mar 31, 2026 | 25,390 | 1.6 | -7.1% |
| Mar 13, 2026 | 27,327 | 2.2 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Unregistered equity saleApr 17, 2026
- Entered a material agreement · Unregistered equity saleMar 16, 2026
- Regulation FD disclosureMar 4, 2026
- Director / officer changeJan 29, 2026
- Regulation FD disclosureJan 22, 2026
- Director / officer changeJan 14, 2026
- Regulation FD disclosureNov 3, 2025
- Director / officer changeOct 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.